Louise Rogers, MD

Dr. Kuykendal has spent many years in North Carolina but has called Charlotte home since 2013. He believes in bringing the latest evidence-based medicine to his patients and working with them to make the best treatment decisions. During his career he has worked in basic science, clinical trials and patient outcomes research to advance the oncology field for current and future patients. He treats patients with a variety of cancers and blood diseases but has a special focus on cancers of the GI tract including colon, rectum, pancreas and liver cancer as well as prostate, kidney and testicular cancer. He has three children who keep him quite busy, and during his free time enjoys sporting events, theater and trying new restaurants.

Steve Martin Jr., MD, is a distinguished medical facility nestled in the vibrant city of Charlotte, NC. Renowned for their exceptional healthcare services, this establishment is a beacon of excellence in the medical field. With a deep-rooted commitment to providing top-notch medical care, Steve Martin Jr., MD, offers a wide array of healthcare solutions tailored to meet the diverse needs of their patients. At Steve Martin Jr., MD, patients can expect nothing but the highest standard of care and professionalism. From primary care to specialized treatments, this facility stands out for its unwavering dedication to promoting wellness and delivering outstanding medical services. With a strong emphasis on patient well-being and innovative healthcare technologies, Steve Martin Jr., MD, is a trusted healthcare partner for individuals seeking reliable and compassionate medical attention in the heart of Charlotte. Generated using this brand's available information

Alan Skarbnik, MD, serves as the director of the lymphoma and chronic lymphocytic leukemia program and director of experimental therapeutics, malignant hematology at Novant Health. Prior to joining Novant Health, Dr. Skarbnik served as the director of the chronic lymphocytic leukemia program at John Theurer Cancer Center at Hackensack University Medical Center. As an expert in chronic lymphocytic leukemia (CLL) and lymphomas, his research focuses on using immunotherapy to improve outcomes of autologous stem cell transplantation for patients with high-risk blood cancers. Dr. Skarbnik is a member of the medical advisory board to the CLL Society and has over 90 peer-reviewed research manuscripts and abstracts in the fields of lymphomas, CLL and stem cell transplantation. Dr. Skarbnik is fluent in English, Spanish and Portuguese. During his free time, he enjoys time with his wife and three children, playing in a rock band and crafting beer.